This report discusses preclinical findings on how Lorcaserin, a serotonin receptor agonist, might help mitigate the negative effects of nicotine withdrawal on neuron maturation in the hippocampus of rats.
Understanding these effects could contribute to developing better treatments for nicotine addiction and withdrawal management in humans.